Evidence map›Paper›PMID 23637958›Full record

ArticlePloS one2013

Impact of alginate composition: from bead mechanical properties to encapsulated HepG2/C3A cell activities for in vivo implantation.

Stephanie H Capone, Murielle Dufresne, Mathias Rechel, Marie-José Fleury, Anne-Virginie Salsac, Patrick Paullier, Martine Daujat-Chavanieu, Cecile Legallais

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 69 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Alginate and alginate composites for biomedical applications.Asian journal of pharmaceutical sciences · 2021
    Review
  15. Article
  16. Article
  17. Article
  18. Hydrogels for Liver Tissue Engineering.Bioengineering (Basel, Switzerland) · 2019
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Stephanie H CaponeUMR CNRS 7338, Laboratory of Biomechanics and Bioengineering, University of Technology, Compiegne, France.
Murielle Dufresne
Mathias Rechel
Marie-José Fleury
Anne-Virginie Salsac
Patrick Paullier
Martine Daujat-Chavanieu
Cecile Legallais
Biomécanique et Bioingénierie · FRCentre National de la Recherche Scientifique · FRInserm · FRInstitute for Regenerative Medicine & Biotherapy · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recently, interest has focused on hepatocytes' implantation to provide end stage liver failure patients with a temporary support until spontaneous recovery or a suitable donor becomes available. To avoid cell damage and use of an immunosuppressive treatment, hepatic cells could be implanted after encapsulation in a porous biomaterial of bead or capsule shape. The aim of this study was to compare the production and the physical properties of the beads, together with some hepatic cell functions, resulting from the use of different material combinations for cell microencapsulation: alginate alone or combined with type I collagen with or without poly-L-lysine and alginate coatings. Collagen and poly-L-lysine increased the bead mechanical resistance but lowered the mass transfer kinetics of vitamin B12. Proliferation of encapsulated HepG2/C3A cells was shown to be improved in alginate-collagen beads. Finally, when the beads were subcutaneously implanted in mice, the inflammatory response was reduced in the case of alginate mixed with collagen. This in vitro and in vivo study clearly outlines, based on a systematic comparison, the necessity of compromising between material physical properties (mechanical stability and porosity) and cell behavior (viability, proliferation, functionalities) to define optima hepatic cell microencapsulation conditions before implantation.

Indexed as

Mechanical PhenomenaMicrospheresAlbuminsAlginatesAnimalsCalciumCapsulesCell ProliferationCell SurvivalCell TransplantationCollagen Type IFemaleGlucoseGlucuronic AcidHep G2 CellsHexuronic AcidsAlbuminsAlginatesCalciumCapsulesCollagen Type IGlucoseGlucuronic AcidHexuronic AcidsPolylysineVitamin B 12

Identifiers

PMID23637958
PMCPMC3636232
OpenAlexW2077712899

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.